Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Total Current Liabilities (2019 - 2023)

Alx Oncology Holdings' Total Current Liabilities history spans 5 years, with the latest figure at $35.1 million for Q3 2023.

  • For Q3 2023, Total Current Liabilities rose 39.21% year-over-year to $35.1 million; the TTM value through Sep 2023 reached $35.1 million, up 39.21%, while the annual FY2022 figure was $28.3 million, 85.19% up from the prior year.
  • Total Current Liabilities for Q3 2023 was $35.1 million at Alx Oncology Holdings, up from $17.6 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $35.1 million in Q3 2023 and bottomed at $5.0 million in Q4 2019.
  • The 5-year median for Total Current Liabilities is $15.3 million (2021), against an average of $16.6 million.
  • The largest annual shift saw Total Current Liabilities skyrocketed 146.53% in 2021 before it dropped 26.64% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $5.0 million in 2019, then increased by 24.48% to $6.2 million in 2020, then surged by 146.53% to $15.3 million in 2021, then skyrocketed by 85.19% to $28.3 million in 2022, then rose by 24.07% to $35.1 million in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Total Current Liabilities are $35.1 million (Q3 2023), $17.6 million (Q2 2023), and $21.9 million (Q1 2023).